Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Goodrx Holdings Inc Cl A (NQ: GDRX )

4.900 +0.610 (+14.22%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Goodrx Holdings Inc Cl A

< Previous 1 2
...
10 11 12 13 14 15 16 17 Next >
Benzinga's Top Ratings Upgrades, Downgrades For September 16, 2022
  
Via Benzinga
What 14 Analyst Ratings Have To Say About GoodRx Holdings
Over the past 3 months, 14 analysts have published their opinion on GoodRx Holdings (NASDAQ:GDRX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2022
Upgrades 
Via Benzinga
What 13 Analyst Ratings Have To Say About GoodRx Holdings
  GoodRx Holdings (NASDAQ:GDRX) has observed the following analyst ratings within the last quarter: 
Via Benzinga
GoodRx to Present at the Goldman Sachs Communacopia + Technology Conference
From GoodRx Holdings, Inc.
Via Business Wire
Looking Into GoodRx Holdings's Return On Capital Employed
GoodRx Holdings (NASDAQ:GDRX) brought in sales totaling $191.80 million during Q2 according to data provided by Benzinga Pro. However, earnings decreased 111.51%, resulting in a loss of $1.42 million. 
Via Benzinga
This Healthcare Stock Dipped Over 30%; Here Are 83 Biggest Movers From Yesterday
Gainers 
Via Benzinga
GoodRx Holdings: Q2 Earnings Insights
  GoodRx Holdings (NASDAQ:GDRX) reported its Q2 earnings results on Monday, August 8, 2022 at 04:07 PM. Here's what investors need to know about the announcement. 
Via Benzinga
GoodRx Holdings, Inc. (NASDAQ: GDRX) Investor Alert: Investigation over Potential Wrongdoing
San Diego, CA -- (SBWIRE) -- 08/15/2022 -- An investigation was announced over potential breaches of fiduciary duties by certain directors at GoodRx Holdings, Inc. 
Via SBWire
The Most Expensive Drug From Novartis Associated With Two Deaths: Report
Two children with spinal muscular atrophy have died after receiving Novartis AG's (NYSE: NVS) Zolgensma, a one-time gene therapy, spotlighting its risks and questioning the safety of genetic medicines... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 12, 2022
  
Via Benzinga
Expert Ratings for GoodRx Holdings
Analysts have provided the following ratings for GoodRx Holdings (NASDAQ:GDRX) within the last quarter: 
Via Benzinga
WeTrade, Roblox And Some Other Big Stocks Moving Lower On Wednesday
  OptimizeRx Corporation (NASDAQ: OPRX) shares fell 26.7% to $16.32 after the company reported worse-than-expected Q2 EPS and sales results and issued FY22 sales guidance below estimates. 
Via Benzinga
Why Verona Pharma Is Trading Higher By Around 84%, Here Are 85 Stocks Moving In Tuesday's Mid-Day Session
Gainers Verona Pharma plc (NASDAQ: VRNA) shares jumped 83.6% to $12.70 after the company announced ensifentrine met its primary endpoint and secondary endpoints in the Phase 3 ENHANCE-2 trial for COPD.... 
Via Benzinga
Qualys, ShockWave Medical, News Corporation And Some Other Big Stocks Moving Higher On Tuesday
  Verona Pharma plc (NASDAQ: VRNA) shares jumped 83.6% to $12.70 after the company announced ensifentrine met its primary endpoint and secondary endpoints in the Phase 3 ENHANCE-2 trial for COPD. The... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
  
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
We're starting off Tuesday with a breakdown of the biggest pre-market stock movers traders will want to keep an eye on today! 
Via InvestorPlace
Why Is BIMI International Medical Higher By Around 70%: Here Are 38 Stocks Moving Premarket
Gainers BIMI International Medical Inc. (NASDAQ: BIMI) shares rose 69.6% to $1.04 in pre-market trading after Fnu Oudom reported a stake of 44% in the company in 13D. 
Via Benzinga
GameStop, Signify Health And Some Other Big Gainers From Monday
U.S. stocks closed mixed on Monday. Here is the list of some big stocks moving higher in the previous session. 
Via Benzinga
Why Karuna Therapeutics Jumped Around 72%; Here Are 96 Biggest Movers From Yesterday
Gainers Helbiz, Inc. (NASDAQ: HLBZ) jumped 114.6% to close at $1.61 on Monday after climbing over 27% on Friday. 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
  
Via Benzinga
GoodRx Releases Second Quarter 2022 Financial Results
From GoodRx Holdings, Inc.
Via Business Wire
GoodRx Offers Free Telehealth Appointments to Kentucky Residents Affected by Flooding
From GoodRx
Via Business Wire
Why CinCor Pharma Is Trading Higher By 63%, Here Are 79 Stocks Moving In Monday's Mid-Day Session
Gainers Bonso Electronics International Inc. (NASDAQ: BNSO) shares jumped 132% to $11.12 after jumping around 46% on Friday. The company recently said it expects unaudited comprehensive loss of $1.6... 
Via Benzinga
GoodRx to Present Virtually at the Bank of America SMID Cap Ideas Conference
From GoodRx Holdings, Inc.
Via Business Wire
These Were The Five Best And Worst Performing Mid-Cap Stocks In H1 2022
Investors who want to make quick returns while having some stability amid the current volatile market environment can go for mid-cap stocks. Let’s take a look at the five best and worst performing... 
Via Talk Markets
16 Analysts Have This to Say About GoodRx Holdings
Over the past 3 months, 16 analysts have published their opinion on GoodRx Holdings (NASDAQ:GDRX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
Is Cloud DX Poised To Innovate Its Way Into The $250 Billion Telehealth Opportunity?
With the outbreak of the COVID-19 pandemic in 2020, telehealth usage reportedly soared to unprecedented levels, as both consumers and health care providers sought ways to safely access and deliver... 
Via Benzinga
GoodRx Announces Date for Second Quarter 2022 Earnings Release and Conference Call
From GoodRx Holdings Inc.
Via Business Wire
Baird Maintains Neutral Rating for GoodRx Holdings: Here's What You Need To Know
Baird has decided to maintain its Neutral rating of GoodRx Holdings (NASDAQ:GDRX) and lower its price target from $7.00 to $6.00. Shares of GoodRx Holdings are trading up 6.94% over the last 24 hours,... 
Via Benzinga
< Previous 1 2
...
10 11 12 13 14 15 16 17 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.